May 31, 2011 - Elekta and ScandiDos AB have entered into a non-exclusive global agreement to distribute ScandiDos's Delta4PT quality assurance (QA) tool. Delta4PT can be used with intensity modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) techniques to provide complete pre-treatment QA that ensures that the dose prescribed in treatment plans is delivered accurately and safely to patients.
Delta4PT, used to verify IMRT and arc therapy delivery techniques since 2006, enables clinicians to verify dose delivery without compromises, in 3-D; instantly analyze and approve plans; evaluate the clinical significance of deviation; and identify the cause of deviations. The benefits are improved efficiency by increasing the volume of patients that can be treated as well as enhanced verification accuracy – enabling more qualified QA decisions to be made.
The agreement will make Delta4PT accessible to the Elekta customer network, further complementing the Elekta QA solutions portfolio and widening the breadth of choices for its customers.
For more information: www.scandidos.com, www.elekta.com
August 09, 2024 
